Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02030769 | Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer | completed | N/A | 1,000 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT01836913 |
| Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal Cancer(RESPECT) |
| completed |
| — |
| 90 |
| University Medical Center GroningenOTHER |
| 1 |
| Mar 23, 2016 |
| clinicaltrials |
| NCT02375581 | Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer | unknown | Phase 2 | 130 | First People's Hospital of HangzhouOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02323776 | Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients | terminated | — | 150 | Maastricht Radiation OncologyOTHER | 1 | Mar 18, 2016 | clinicaltrials |
| NCT00390416 | Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma | completed | Phase 2 | 48 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00757172 | Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT01733719 | Barrett&Apos;s Intervention for Dysplasia by Endoscopy(BRIDE) | completed | N/A | 76 | University Hospitals, LeicesterOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT02385604 | The Predictive Value of CT-PET in Esophageal Cancer | completed | — | 250 | St. James's Hospital, IrelandOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT02693236 | DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer | unknown | Phase 1 / Phase 2 | 30 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT01980394 | Esophageal Stump Washout | completed | N/A | 50 | Kantonsspital LiestalOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01854749 | S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study | completed | Phase 2 | 57 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01551641 | Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer | unknown | Phase 2 | 180 | Changzhou No.2 People's HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02607982 | CCRT for Esophageal Cancer. | completed | Phase 2 | 34 | Hangzhou Cancer HospitalOTHER | 0 | Feb 17, 2016 | clinicaltrials |
| NCT02683655 | Study of Apatinib in Metastatic Esophageal Cancer | unknown | Phase 2 | 40 | Huai'an First People's HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00130936 | Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates | terminated | Phase 1 / Phase 2 | 50 | AHS Cancer Control AlbertaOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT02677597 | Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 268 | Fudan UniversityOTHER | 1 | Feb 9, 2016 | clinicaltrials |
| NCT00737438 | Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | completed | Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT00747448 | CryoSpray Ablation (TM) GI Patient Registry | completed | — | 199 | CSA Medical, Inc.INDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT02611700 | Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 504 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT02665702 | Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas | unknown | Phase 2 | 76 | Fudan UniversityOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT00590031 | Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. | completed | Phase 2 | 61 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT02662348 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | unknown | Phase 1 | 6 | Yi MiaoOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT02283359 | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus | terminated | Phase 1 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT02607540 | Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer(PFCRTESC) | unknown | Phase 3 | 210 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00383266 | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer | terminated | Phase 2 | 9 | Washington University School of MedicineOTHER | 1 | Jan 11, 2016 | clinicaltrials |
| NCT00515216 | Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors | completed | Phase 2 | 26 | Vanderbilt UniversityOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT00586989 | Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus(ETMI) | completed | — | 60 | Mayo ClinicOTHER | 2 | Jan 7, 2016 | clinicaltrials |
| NCT00268346 | Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer | completed | Phase 2 | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT01469598 | Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01474642 | Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 64 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01242124 | Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy | unknown | Phase 2 / Phase 3 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | completed | Phase 2 / Phase 3 | 266 | UNICANCEROTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02042313 | Postoperative Pain Management After Minimally Invasive Esophagectomy(MIEPVBEA) | unknown | Phase 4 | 58 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT02628665 | Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer | unknown | Phase 3 | 40 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT02302118 | Esophagogastrectomy Versus Extended Gastrectomy in AEG II(AEG-II-EG) | completed | — | 128 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT00220077 | Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer | unknown | N/A | 400 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT00397904 | Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | completed | Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | withdrawn | Phase 3 | 0 | Shantou University Medical CollegeOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | unknown | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00109850 | S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | terminated | Phase 2 | 22 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00011960 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02603159 | Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy(DCECRT) | unknown | Phase 3 | 200 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT00754468 | Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.(ESODOI) | completed | Phase 4 | 7 | CSA Medical, Inc.INDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT02586753 | Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 2 | Mianyang Central HospitalOTHER | 0 | Oct 26, 2015 | clinicaltrials |
| NCT01998230 | Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer | completed | Phase 3 | 280 | Yin LiOTHER_GOV | 1 | Oct 16, 2015 | clinicaltrials |
| NCT02570893 | A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 366 | Zhejiang Cancer HospitalOTHER | 1 | Oct 7, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Mar 29, 2016source: clinicaltrials